Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Specialties
Publications
Articles from Mary Thompson:
Read all from this author
Business Strategies

ADA 2024: The Beat Goes On

  • July 30, 2024
  • Mary Thompson
  • MedTech Strategist

Growth is the name of the game in the diabetes device market as companies with automated insulin delivery systems, including Insulet, Tandem Diabetes Care, and Medtronic, push into the type 2 space, while Abbott and Dexcom, suppliers of continuous glucose monitoring devices, eye even broader opportunities with newly cleared over-the-counter CGM systems. Much of the ongoing innovation was on display at the American Diabetes Association meeting, held recently in Orlando, FL.

Read Article